Quinupramine

This classification denotes a dibenzazepine and quinuclidine with the molecular formula C21H24N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 29O61HFF4L, chemically known as 10,11-dihydro-5-(3-quinuclidinyl)-5h-dibenz(b,f)azepine but generally known as quinupramine, which bears US NIH Compound Identifier 93154. European Medicines Agency schedules Quinupramine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10225MIG. World Health Organization schedules quinupramine in its Anatomical Therapeutic Chemical (ATC) Classification. QUINUPRAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quinupramine under HS 29333999 and SITC 51574. As of Q4 2014, QUINUPRAMINE remains the US FDA Preferred Term for this commodity. SMILES: N12CC(N3C4C(CCC5C3CCCC5)CCCC4)C(CC1)CC2.